hydroxyl radical has been researched along with Mental Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashihara, E; Inden, M; Kitamura, Y; Takata, K; Yasui, H; Yoshimoto, K | 1 |
| Dennis, DM; Glushakov, AV; Gravenstein, N; Martynyuk, AE; Seubert, CN; Sumners, C; Yarotskyy, V | 1 |
1 review(s) available for hydroxyl radical and Mental Disorders
| Article | Year |
|---|---|
Halogenated derivatives of aromatic amino acids exhibit balanced antiglutamatergic actions: potential applications for the treatment of neurological and neuropsychiatric disorders.
Topics: Animals; Brain; Brain Diseases; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Hydroxyl Radical; Mental Disorders; Neuroprotective Agents; Phenylalanine; Synaptic Transmission; Tyrosine | 2006 |
1 other study(ies) available for hydroxyl radical and Mental Disorders
| Article | Year |
|---|---|
Detoxification of 6-hydroxydopamine-induced dopaminergic neurodegeneration by 5,5-dimethyl-1-pyrroline N-oxide, a radical trapper, in hemiparkinsonian rats.
Topics: Animals; Antioxidants; Behavior, Animal; Cyclic N-Oxides; Disease Models, Animal; Dose-Response Relationship, Drug; Hydroxyl Radical; Iron; Male; Mental Disorders; Oxidative Stress; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra; Tyrosine 3-Monooxygenase | 2012 |